首页> 外国专利> SCHISTOSOMA HAEMATOBIUM RECOMBINANT FUSION PROTEIN SHSAP AND APPLICATION THEREOF IN IMMUNODIAGNOSIS OF SCHISTOSOMIASIS

SCHISTOSOMA HAEMATOBIUM RECOMBINANT FUSION PROTEIN SHSAP AND APPLICATION THEREOF IN IMMUNODIAGNOSIS OF SCHISTOSOMIASIS

机译:血吸虫血沸石重组融合蛋白SHSAP及其在血吸虫病免疫诊断中的应用

摘要

A Schistosoma haematobium recombinant fusion protein ShSAP and an application thereof in the immunodiagnosis of schistosomiasis. The Schistosoma haematobium recombinant fusion protein ShSAP can undergo large-scale standardized mass production by means of genetic engineering technology, antigen quality is stable and the repeatability of the results is good. The fusion protein can be used for the immunodiagnosis of both schistosomiasis haematosis and schistosomiasis mansoni, and has extremely high sensitivity. The Schistosoma haematobium recombinant fusion protein ShSAP has a single antigen component, and ShSAP-ELISA has excellent specificity for the immunodiagnosis of schistosomiasis. The fusion protein does not cross-react with the serum of a patient suffering from another parasitic disease, and has broad application prospects.
机译:血吸虫血磷重组融合蛋白SHSAP及其在血吸虫病免疫诊断中的应用。 Schistosoma Haemakobium重组融合蛋白SHSAP可以通过基因工程技术进行大规模标准化批量生产,抗原质量稳定,结果的可重复性是好的。融合蛋白可用于血吸虫病血症血症和血吸虫病曼逊的免疫诊断,具有极高的灵敏度。血吸虫血磷重组融合蛋白SHSAP具有单一抗原组分,SHSAP-ELISA对血吸虫病免疫诊断具有优异的特异性。融合蛋白不会与患有患有另一种寄生疾病的患者的血清交叉反应,并且具有广泛的应用前景。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号